Please login to the form below
Dramatic shifts in pharma drive patient needs to trump all – including C-Suite authority
eyeforpharma, London (January, 19, 2015): According to LEO Pharma, Ipsen and Grünenthal driving patient-centric leadership has become priority as the patient voice shapes the future for the pharmaceutical industry.
Speaking ahead of the
eyeforpharma Barcelona 2015 conference, Alberto Grua, CCO at Grünenthal echoed similar industry commitments to putting
patient’s needs to the forefront of their decision making, and stressed Grünenthals
personal commitment to leading a patient-centric culture:
“We regard it as our job to better understand the unmet needs of our patients and to provide them with even better products in the future. We want to place the patient at the centre of our efforts. Our goal is to sustainably improve the life situation of patients. That is why we continue to search for possibilities, progress in therapies, collaborations and innovations to reach this goal”.
Alberto Grua will be joined by CEOs Gitte Aabo at Leo Pharma and Marc de Garidel at Ipsen. All three join Barcelona 2015 to demonstrate what patient-centric leadership looks like, and how the industry will evolve based on this emerging paradigm. The event, the largest commercial gathering of pharmaceutical companies in the world, will be attended by all of the key players including UCB, Novartis, Pfizer, Merck, Bayer and Sanofi. The goal? To explore business models which align patient experience with profitability.
Today’s well-informed, well-equipped patient has challenged the industry. To keep ahead of the increasing patient voice, change must start from the top. CEOs are needed to drive innovation and transformation, while continuing to execute current business necessities. The CEO is now responsible for organising a patient-centric leadership which drives the agenda through the entire value chain, ensuring every department can embed new practices and ensure patient needs trump all.
Over 1000 senior pharmaceutical and healthcare executives will join the CEO panel at the summit; which will take place from 24th-26th March, 2015. For more information on the summit, to see who else will be in attendance, or to find out how this year’s agenda will influence your future business practices visit the official website.
For more information contact:
Blair Gottscho
EyeforPharma
(+44) 207-375-7594
blair@eyeforpharma.com
“We regard it as our job to better understand the unmet needs of our patients and to provide them with even better products in the future. We want to place the patient at the centre of our efforts. Our goal is to sustainably improve the life situation of patients. That is why we continue to search for possibilities, progress in therapies, collaborations and innovations to reach this goal”.
Alberto Grua will be joined by CEOs Gitte Aabo at Leo Pharma and Marc de Garidel at Ipsen. All three join Barcelona 2015 to demonstrate what patient-centric leadership looks like, and how the industry will evolve based on this emerging paradigm. The event, the largest commercial gathering of pharmaceutical companies in the world, will be attended by all of the key players including UCB, Novartis, Pfizer, Merck, Bayer and Sanofi. The goal? To explore business models which align patient experience with profitability.
Today’s well-informed, well-equipped patient has challenged the industry. To keep ahead of the increasing patient voice, change must start from the top. CEOs are needed to drive innovation and transformation, while continuing to execute current business necessities. The CEO is now responsible for organising a patient-centric leadership which drives the agenda through the entire value chain, ensuring every department can embed new practices and ensure patient needs trump all.
Over 1000 senior pharmaceutical and healthcare executives will join the CEO panel at the summit; which will take place from 24th-26th March, 2015. For more information on the summit, to see who else will be in attendance, or to find out how this year’s agenda will influence your future business practices visit the official website.
For more information contact:
Blair Gottscho
EyeforPharma
(+44) 207-375-7594
blair@eyeforpharma.com
